Use of the aminoalkylindole jwh-073-m4 and related compounds as neutral cb1 recptor antagonists for the treatment of alcoholism, drug abuse, obesity, and obesity-related diseases
作者： Anna Radominska-Pandya , Jefferey Moran , Lisa K. Brents , Paul L. Prather , Tamara Vasiljevik
DOI:
关键词:
摘要: Novel alkylindoles that bind tightly to cannabinoid receptors and are neutral antagonists for the 1 receptor agonists 2 provided. These compounds useful treating alcoholism drug abuse obesity.
lens.org 参考文章(33)
Sándor Bátkai, Zoltán Járai, Jens A. Wagner, Sravan K. Goparaju, KÁroly Varga, Jie Liu, Lei Wang, Faridoddin Mirshahi, Atmaram D. Khanolkar, Alexandros Makriyannis, Renata Urbaschek, Nelson Garcia, Arun J. Sanyal, George Kunos, Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis Nature Medicine. ,vol. 7, pp. 827- 832 ,(2001) , 10.1038/89953
Brady K Atwood, John Huffman, Alex Straiker, Ken Mackie, JWH018, a common constituent of ‘Spice’ herbal blends, is a potent and efficacious cannabinoid CB1 receptor agonist British Journal of Pharmacology. ,vol. 160, pp. 585- 593 ,(2010) , 10.1111/J.1476-5381.2009.00582.X
Paul L. Prather, Steven R. Childers, Nancy A. Martin, Christopher S. Breivogel, Activation of Cannabinoid Receptors in Rat Brain by WIN 55212-2 Produces Coupling to Multiple G Protein α-Subunits with Different Potencies Molecular Pharmacology. ,vol. 57, pp. 1000- 1010 ,(2000)
Christian Congy, Didier Oustric, Richard E. Philion, Francis Barth, Pierre Casellas, Malcolm R. Bell, Thomas E. D'Ambra, Murielle Rinaldi, Cb2 receptor agonist compounds ,(1996)
L. Mikasova, L. Groc, D. Choquet, O. J. Manzoni, Altered surface trafficking of presynaptic cannabinoid type 1 receptor in and out synaptic terminals parallels receptor desensitization Proceedings of the National Academy of Sciences of the United States of America. ,vol. 105, pp. 18596- 18601 ,(2008) , 10.1073/PNAS.0805959105
Adèle Thomas, Lesley A Stevenson, Kerrie N Wease, Martin R Price, Gemma Baillie, Ruth A Ross, Roger G Pertwee, Evidence that the plant cannabinoid Δ9-tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonist British Journal of Pharmacology. ,vol. 146, pp. 917- 926 ,(2005) , 10.1038/SJ.BJP.0706414
Vincenzo Di Marzo, Isabel Matias, Endocannabinoid control of food intake and energy balance Nature Neuroscience. ,vol. 8, pp. 585- 589 ,(2005) , 10.1038/NN1457
Ting Qi, Wenfeng Qiu, Yunqi Liu, Hengjun Zhang, Xike Gao, Ying Liu, Kun Lu, Chunyan Du, Gui Yu, Daoben Zhu, Synthesis, Structures, and Properties of Disubstituted Heteroacenes on One Side Containing Both Pyrrole and Thiophene Rings Journal of Organic Chemistry. ,vol. 73, pp. 4638- 4643 ,(2008) , 10.1021/JO800622Y
Ezra Gabbay, Yosefa Avraham, Yaron Ilan, Eran Israeli, Elliot M. Berry, Endocannabinoids and liver disease – review Liver International. ,vol. 25, pp. 921- 926 ,(2005) , 10.1111/J.1478-3231.2005.01180.X
F. Xavier Pi-Sunyer, Louis J. Aronne, Hassan M. Heshmati, Jeanne Devin, Julio Rosenstock, for the RIO-North America Study Group, Effect of Rimonabant, a Cannabinoid-1 Receptor Blocker, on Weight and Cardiometabolic Risk Factors in Overweight or Obese Patients JAMA. ,vol. 295, pp. 761- 775 ,(2006) , 10.1001/JAMA.295.7.761